NCT04800614View on ClinicalTrials.gov

A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

July 6, 2021

Study Completion Date

March 28, 2022

Conditions
Healthy Adults
Interventions
DRUG

sitravatinib

100 mg sitravatinib on Day 1 of each of 3 periods

Trial Locations (1)

75247

Covance Clinical Research Unit, Inc., Dallas

Sponsors
All Listed Sponsors
lead

Mirati Therapeutics Inc.

INDUSTRY

NCT04800614 - A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib | Biotech Hunter | Biotech Hunter